Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunshine Database Could Aid Pharma In Defense Against DOJ Suits

Executive Summary

Former federal prosecutor Michael Loucks notes that companies can use information about competitors’ payments to physicians in defending themselves against charges they paid to induce prescribing.

You may also be interested in...



“Sunshine” Might Bring Public Awareness Campaign On Medical Research

Final CMS reg on reporting industry payments to physicians include limiting coverage to companies operating in the U.S. and a definition of third-party payments; despite wins in the revisions from the proposed rule, industry may need a widespread education campaign in order to preserve the value of its physician relationships.

GSK’s DoJ Settlement Links Executive Bonus To Continued Compliance

GlaxoSmithKline pleads guilty to marketing Paxil and Wellbutrin off-label and concealing Avandia safety data from FDA and resolves allegations of kickbacks involving nine drugs; ground-breaking corporate integrity agreement includes novel recoup of bonuses from execs if they or their subordinates engage in “significant misconduct.”

Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says

Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.

Topics

Related Companies

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel